M Holtkamp
Overview
Explore the profile of M Holtkamp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Benninger F, Holtkamp M
Nervenarzt
. 2017 Jun;
88(10):1197-1207.
PMID: 28616696
Following stroke, 3-6% of patients develop acute symptomatic seizures within the first 7 days. The rate is higher after cerebral haemorrhage compared to ischaemia. In 10-12% of patients, after more...
2.
Thyssen G, Holtkamp M, Kaulfurst-Soboll H, Wehe C, Sperling M, von Schaewen A, et al.
Metallomics
. 2017 May;
9(6):676-684.
PMID: 28504297
Laser ablation-inductively coupled plasma-optical emission spectroscopy (LA-ICP-OES) is presented as a valuable tool for elemental bioimaging of alkali and earth alkali elements in plants. Whereas LA-ICP-OES is commonly used for...
3.
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies
Shorvon S, Trinka E, Steinhoff B, Holtkamp M, Villanueva V, Peltola J, et al.
J Neurol
. 2017 Jan;
264(3):421-431.
PMID: 28101651
Eslicarbazepine acetate (ESL) is a once-daily antiepileptic drug that is approved as adjunctive therapy in adults with focal-onset seizures. Following oral administration, ESL is rapidly metabolized to its active metabolite,...
4.
Bien C, Mirzadjanova Z, Baumgartner C, Onugoren M, Grunwald T, Holtkamp M, et al.
Eur J Neurol
. 2016 Oct;
24(1):175-186.
PMID: 27786401
Background And Purpose: To clarify the relevance of titres of IgG antibodies against contactin-associated protein-2 (CASPR2) in diagnosing anti-CASPR2 encephalitis and to describe features and outcomes. Methods: This was a...
5.
Losch F, Holtkamp M, McMurray R, Lendemans D, Kockelmann E
Nervenarzt
. 2016 Aug;
87(10):1094-1099.
PMID: 27550387
Background: Due to inadequate seizure control achieved with antiepileptic drug (AED) monotherapy and the considerable side effects at high required doses, patients with partial-onset seizures (POS) often require AED combination...
6.
Holtkamp M, McMurray R, Bagul M, Sousa R, Kockelmann E
Acta Neurol Scand
. 2016 Feb;
134(1):76-82.
PMID: 26915469
Objective: To assess retention, tolerability, and safety, efficacy and effects on quality of life (QoL) of eslicarbazepine acetate (ESL) add-on treatment over 6 months in a real-world adult population with...
7.
Borgmann M, Holtkamp M, Adli M, Behr J
Nervenarzt
. 2015 Nov;
87(7):724-30.
PMID: 26597274
Background: Epilepsy and depressive disorders show a high rate of comorbidity. Thus, neurobiological similarities and a bidirectional relationship in terms of pathogenesis have been suggested. Objectives: The aim of this...
8.
Kowski A, Volz M, Holtkamp M, Pruss H
Eur J Neurol
. 2013 Oct;
21(3):395-401.
PMID: 24112402
Background And Purpose: The influence of the immune system on seizures and epileptogenesis has been increasingly considered, in particular the role of autoantibodies. In this study, we aimed to determine...
9.
Hamerle M, Ghaeni L, Kowski A, Weissinger F, Holtkamp M
Eur J Neurol
. 2013 Jan;
21(1):167-70.
PMID: 23311572
Background And Purpose: This study aimed to assess the prevalence of illicit drug use among epilepsy patients and its effects on the disease. Methods: We systematically interviewed epilepsy outpatients at...
10.
Duchaczek B, Ghaeni L, Matzen J, Holtkamp M
Eur J Neurol
. 2013 Jan;
20(10):1360-6.
PMID: 23279753
Background And Purpose: Interictal headache (IIH), and in particular migraine, is considered a relevant co-morbidity in epilepsy; however, available data are ambiguous. Periictal headache (PIH) displays a frequent ancillary burden...